Company Performance Metrics
Kubota Vision develops ophthalmic drugs and devices to preserve and restore vision. The company focuses on therapies for debilitating ocular diseases, including late-stage investigational medicines such as emixustat for Stargardt disease. Kubota Vision advances vision care technologies that may be used in specialized environments such as space
programs and plans to commercialize similar technology for eyecare professionals, healthcare providers, and individuals. Its portfolio includes device-based approaches like Kubota Glass, which uses micro-LED projections in the peripheral visual field to aid myopia management. The organization conducts research and product development supported in part by external grants and follows formal compliance policies for financial conflicts of interest and clinical research conduct.
